Issue 1/2006
Content (15 Articles)
Activation of mitogenic pathways and sensitization to estrogen-induced apoptosis: two independent characteristics of tamoxifen-resistant breast cancer cells?
Alexander M. Scherbakov, Yulia S. Lobanova, Valentina A. Shatskaya, Oksana V. Onopchenko, Elena S. Gershtein, Mikhail A. Krasil’nikov
GnRH analogs reduce invasiveness of human breast cancer cells
Julia von Alten, Stefanie Fister, Hiltrud Schulz, Volker Viereck, Karl-Heinz Frosch, Günter Emons, Carsten Gründker
Assessment of multiple different estrogen receptor-β antibodies for their ability to immunoprecipitate under chromatin immunoprecipitation conditions
Gregory E. Weitsman, George Skliris, Kanyarat Ung, Baocheng Peng, Mamoun Younes, Peter H. Watson, Leigh C. Murphy
Proteasome Inhibitors Induce a p38 Mitogen-activated Protein Kinase (MAPK)-dependent Anti-apoptotic Program Involving MAPK Phosphatase-1 and Akt in Models of Breast Cancer
Yue Y. Shi, George W. Small, Robert Z. Orlowski
Secreted Frizzled Related Protein 2 (sFRP2) Decreases Susceptibility to UV-Induced Apoptosis in Primary Culture of Canine Mammary Gland Tumors by NF-κB Activation or JNK Suppression
Jia-Lin Lee, Ching-Jin Chang, Ling-Ling Chueh, Chung-Tien Lin
Premature Menopause in Patients with BRCA1 Gene Mutation
Izabella Rzepka-Górska, Bogusław Tarnowski, Anita Chudecka-Głaz, Bohdan Górski, Dorota Zielińska, Aleksandra Tołoczko-Grabarek
Cosmetic outcomes following breast conservation therapy: in search of a reliable scale
Amanda J. Fortin, Mary Cheang, Steven Latosinsky
Estrogen Receptor Expression in Benign Breast Ductal Cells Obtained from Random Periareolar Fine Needle Aspiration Correlates with Menopausal Status and Cytomorphology Index Score
Priyanka Sharma, Bruce F. Kimler, Chezna Warner, Trina Metheny, Qiao Xue, Carola M. Zalles, Carol J. Fabian
Intensity of diagnostic and treatment activities during the end of life of patients with advanced breast cancer
R. Asola, H. Huhtala, K. Holli
Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families
Giuseppe Giannini, Carlo Capalbo, Elisabetta Ristori, Enrico Ricevuto, Tina Sidoni, Amelia Buffone, Enrico Cortesi, Paolo Marchetti, Giovanni Scambia, Silverio Tomao, Christian Rinaldi, Massimo Zani, Sergio Ferraro, Luigi Frati, Isabella Screpanti, Alberto Gulino
Interaction of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferase M1 to breast cancer in Taiwanese woman without smoking and drinking habits
Szu-Hsien Wu, Shih-Meng Tsai, Ming-Feng Hou, Hung-Shiun Lin, Linda Ann Hou, Hsu Ma, Jin-Teh Lin, Fa-Lai Yeh, Li-Yu Tsai
CHEK2 1100delC mutation is frequent among Russian breast cancer patients
Elena V. Chekmariova, Anna P. Sokolenko, Konstantin G. Buslov, Aglaya G. Iyevleva, Yulia M. Ulibina, Maxim E. Rozanov, Natalia V. Mitiushkina, Alexandr V. Togo, Dmitry E. Matsko, Dmitry A. Voskresenskiy, Oleg L. Chagunava, Peter Devilee, Cees Cornelisse, Vladimir F. Semiglazov, Evgeny N. Imyanitov
Genetic determinants of bone mass do not relate with breast cancer risk in US white and African-American women
Pamela J. VandeVord, Paul H. Wooley, Linda L. Darga, Richard K. Severson, Bin Wu, Dorothy A. Nelson
Factors Affecting Sensitivity and Specificity of Screening Mammography and MRI in Women with an Inherited Risk for Breast Cancer
Mieke Kriege, Cecile T. M. Brekelmans, Inge Marie Obdeijn, Carla Boetes, Harmine M. Zonderland, Sara H. Muller, Theo Kok, Radu A. Manoliu, A. Peter E. Besnard, Madeleine M. A. Tilanus-Linthorst, Caroline Seynaeve, Carina C. M. Bartels, Reini Kaas, Siebren Meijer, Jan C. Oosterwijk, Nicoline Hoogerbrugge, Rob A. E. M. Tollenaar, Emiel J. T. Rutgers, Harry J. de Koning, Jan G. M. Klijn
Effects of Estrogen Receptor Expression and Histopathology on Annual Hazard Rates of Death from Breast Cancer
William F. Anderson, Bingshu E. Chen, Ismail Jatoi, Philip S. Rosenberg